| Product dosage: 0.5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.90 | $57.08 (0%) | 🛒 Add to cart |
| 60 | $1.80 | $114.16 $108.15 (5%) | 🛒 Add to cart |
| 90 | $1.77 | $171.24 $159.23 (7%) | 🛒 Add to cart |
| 120 | $1.75 | $228.33 $210.30 (8%) | 🛒 Add to cart |
| 180 | $1.74 | $342.49 $312.45 (9%) | 🛒 Add to cart |
| 270 | $1.72
Best per pill | $513.73 $464.66 (10%) | 🛒 Add to cart |
Similar products
More info:
Dutas: Comprehensive DHT Suppression for Prostate and Hair Conditions - Evidence-Based Review
Dutasteride, marketed under brand names including Dutas, represents a significant advancement in 5-alpha reductase inhibitor therapy. This prescription medication belongs to the same class as finasteride but with distinct pharmacological properties that make it particularly valuable in specific clinical scenarios. As a dual inhibitor of both type 1 and type 2 isoforms of the 5-alpha reductase enzyme, dutasteride achieves more complete suppression of dihydrotestosterone (DHT) conversion from testosterone. This mechanism underlies its primary applications in benign prostatic hyperplasia management and, in some regions, androgenetic alopecia treatment.
Avodart: Significant Prostate Volume Reduction for BPH - Evidence-Based Review
Product Description Avodart (dutasteride) is a prescription medication in the 5-alpha-reductase inhibitor class, specifically formulated as a soft gelatin capsule containing 0.5 mg dutasteride. It’s primarily indicated for the management of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate. Unlike over-the-counter supplements, Avodart requires careful medical supervision due to its potent and permanent effects on hormone pathways. 1. Introduction: What is Avodart? Its Role in Modern Medicine When we’re talking about medical management of benign prostatic hyperplasia, Avodart represents one of the more impactful developments in urology over the past two decades.
finast
Finast represents one of those interesting cases where a dietary supplement formulation bridges traditional herbal knowledge with modern pharmaceutical-grade standardization. We’re looking at a saw palmetto extract specifically engineered for maximum bioavailability, targeting androgen-related conditions with a precision that’s frankly unusual in the supplement space. The core challenge with saw palmetto has always been the lipophilic nature of its active compounds - the fatty acids just don’t absorb well in standard preparations.
finpecia
Finpecia is the brand name for finasteride 1mg tablets, a prescription medication specifically formulated for the treatment of male pattern hair loss (androgenetic alopecia) in men. It represents one of the few clinically proven, FDA-approved oral treatments for this condition, operating through a well-understood hormonal pathway. Its role has evolved from its origin as a higher-dose (5mg) prostate medication, becoming a cornerstone in dermatological practice for managing progressive hair thinning.
flomax
Flomax, known generically as tamsulosin hydrochloride, is an alpha-1 adrenergic receptor blocker specifically formulated for the management of lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). It’s not a dietary supplement but a prescription medication that selectively relaxes smooth muscle in the prostate and bladder neck, facilitating improved urinary flow. Its role in modern urology is well-established, offering a targeted approach that minimizes the blood pressure effects seen with non-selective alpha-blockers.
himplasia
Himplasia represents one of those interesting botanical formulations that bridges traditional Ayurvedic medicine with modern urological practice. As a prostate health supplement containing standardized extracts of Tribulus terrestris, Caesalpinia bonduc, Asteracantha longifolia, and other herbs, it’s manufactured by Himalaya Herbals and has been used clinically for benign prostatic hyperplasia (BPH) management for decades. What makes it particularly noteworthy isn’t just the ingredient combination but the specific standardization process Himalaya employs, which creates more consistent clinical effects than many generic herbal blends.
propecia
Propecia, known generically as finasteride, is a prescription medication specifically formulated at a 1 mg dose for the treatment of male pattern hair loss (androgenetic alopecia) in men. It belongs to a class of drugs called 5-alpha-reductase inhibitors. Originally developed and studied at a 5 mg dose for treating benign prostatic hyperplasia (BPH), researchers observed an interesting side effect – hair growth. This serendipitous finding led Merck to pursue the 1 mg formulation specifically for hair loss, which received FDA approval in 1997.
proscare
Prostate health management has evolved significantly over the past decade, with Proscare emerging as one of the more interesting developments in our urology practice. I remember when we first started seeing patients asking about this supplement - initially dismissed it as another overhyped product, but the clinical results have been surprisingly consistent across our patient population. ## 1. Introduction: What is Proscare? Its Role in Modern Medicine Proscare represents a novel approach to prostate health management, specifically formulated to address the multifactorial nature of benign prostatic hyperplasia (BPH) and associated urinary symptoms.
Uroxatral: Rapid Symptom Relief for BPH - Evidence-Based Review
Uroxatral, known generically as alfuzosin, is an alpha-1 adrenergic receptor antagonist specifically indicated for the symptomatic management of benign prostatic hyperplasia (BPH). Unlike non-selective alpha-blockers, its uroselective profile targets receptors predominantly in the prostate and bladder neck, offering relief from obstructive and irritative urinary symptoms while minimizing systemic cardiovascular effects. This specificity makes it a cornerstone in BPH management algorithms. 1. Introduction: What is Uroxatral? Its Role in Modern Medicine Uroxatral represents a significant advancement in the pharmacological management of benign prostatic hyperplasia, affecting approximately 50% of men over 60.